Securities Code: 301156
Securities Abbreviation: Meino Biological
Announcement Number: 2026-034
Shanghai Meino Biological Technology Co., Ltd. announces the pre-disclosure of the share reduction plan by certain directors and senior management. Director and senior manager Xiong Ying guarantees that the information provided to the company is true, accurate, and complete, with no false records, misleading statements, or significant omissions. The company and all members of the board guarantee that the announcement content is consistent with the information provided by the information disclosure obligor.
Special Reminder:
- As of the date of this announcement, the total share capital of Shanghai Meino Biological Technology Co., Ltd. (hereinafter referred to as "the Company") is 183,020,077 shares.
- Xiong Ying, who holds 4,857,823 shares (accounting for 2.65% of the total share capital), plans to reduce his holdings by no more than 1,214,456 shares (accounting for 0.6636% of the total share capital) through centralized bidding or block trading within three months after 15 trading days from the date of this announcement. Recently, the company received a notice from director and senior manager Xiong Ying regarding the share reduction plan, and the specific matters are announced as follows:
1. Basic Information of the Shareholder
As of the date of this announcement, the specific shareholding situation of shareholder Xiong Ying who intends to reduce his shares is as follows:
| No. | Shareholder Name | Position | Total Shares Held | Percentage of Total Share Capital |
|---|---|---|---|---|
| 1 | Xiong Ying | Director, Deputy General Manager | 4,857,823 | 2.65% |